Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124195) titled 'Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting' on Aug. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Condition:
Malignant Solid Tumors
Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs
Intervention:
Drug: Medroxyprogesterone acetate oral suspension
Combination Product: high antiemetic regimen
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: August ...